Clinical Trial Update: Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study of minor histocompatibility vaccination after allogeneic stem cell transplantation for advanced hematologic malignancies has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Lymphoma
• Myeloma
• Myeloproliferative Disorders
• Preleukemia

Drugs mentioned

• Minor Histocompatibility Vaccination

Snippet

Sponsor: University of Chicago | Conditions: Preleukemia, Myeloproliferative Disorders | Phase 1 | Status: TERMINATED